Tumor growth rate for prognostic stratification and treatment optimization in unresectable hepatocellular carcinoma treated with TACE combined with systemic therapy

Abstract Background Tumor growth rate (TGR) is a dynamic biomarker for evaluating therapeutic response and prognosis in unresectable hepatocellular carcinoma (uHCC) with triple therapy, yet its clinical utility and role in guiding treatment optimization require further validation. Methods This study...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Guobin Chen, Meixia Wang, Xing Huang, Zhenzhen Zhang, Yanfang Wu, Xiaochun Chen, Xinkun Guo, Susu Zheng, Tanghui Zheng, Hong Chen, Jingfang Wu, Boheng Zhang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-01-01
Serija:	BMC Gastroenterology
Teme:	Hepatocellular carcinoma Tumor growth rate Transarterial chemoembolization Immune checkpoint inhibitors Angiogenesis inhibitors
Online dostop:	https://doi.org/10.1186/s12876-025-04596-2
Oznake:	Označite Brez oznak, prvi označite!